Summary
Definition
History and exam
Key diagnostic factors
- história recente de imersão em banheiras de spa
- é sabido que o início de um novo medicamento está associado à foliculite
Other diagnostic factors
- história recente de barbear
- pápulas umbilicadas, cor de pele
- pápulas em um lado da face na área submandibular
- pápulas e pústulas pequenas e uniformes
- histórico de eritema
- alopécia/descamação do couro cabeludo
- placas eritematosas com crostas hemorrágicas em uma distribuição dermatomal
Risk factors
- trauma, incluindo raspagem e extração
- preparos de corticosteroide tópico
- diabetes mellitus
- imunossupressão
- oclusão e transpiração
- antibióticos sistêmicos
- imersão em água com nível insuficiente de cloro
- medicamentos
Diagnostic investigations
Investigations to consider
- swab de pele para infecção bacteriana
- swab de pele para infecção viral
- esfregaço de pele para micologia
- cultura de tecido
- biópsia de pele
Treatment algorithm
foliculite superficial não complicada, organismo desconhecido
foliculite recorrente/profunda por Staphylococcus aureus suscetível à meticilina (SASM)
foliculite recorrente/profunda por Staphylococcus aureus resistente à meticilina (MRSA)
foliculite Gram-negativa
foliculite de banheira de hidromassagem causada por infecção por Pseudomonas aeruginosa
foliculite dermatofítica
Malassezia furfur (foliculite por Pityrosporum)
foliculite por Candida
foliculite por vírus do herpes simples (HSV)
foliculite por Demodex folliculorum
foliculite induzida por medicamentos
foliculite pustulosa eosinofílica (doença de Ofuji)
foliculite eosinofílica associada ao vírus da imunodeficiência humana (HIV)
foliculite pustulosa eosinofílica na infância
Contributors
Authors
Joshua Hekmatjah, BS
Clinical Research Fellow
Dermatology Department
Keck School of Medicine of USC
University of Southern California
Los Angeles
CA
Disclosures
JH declares that he has no competing interests.
Nazanin Ehsani-Chimeh, MD
Clinical Research Fellow
Dermatology Department
Keck School of Medicine of USC
University of Southern California
Los Angeles
CA
Disclosures
NEC declares that she has no competing interests.
April W. Armstrong, MD, MPH
Associate Dean, Clinical Research
Associate Professor of Dermatology
Keck School of Medicine of USC
University of Southern California
Los Angeles
CA
Disclosures
AWA has served as an investigator for Abbvie, Bristol-Myers-Squibb, Dermavent, Janssen, Eli Lilly, Modernizing Medicine, Novartis, OrthoDermalogics, Pfizer, Regeneron Pharmaceuticals, Sanofi Genzyme, and Sun Pharma; has been a speaker for Abbvie, Regeneron, and Sanofi Genzyme; and is a member of the data safety monitoring board for Boehringer Ingelheim/Paraxel. Her institution has received funding from Bristol-Myers-Squibb, Dermavent, Dermira, Eli Lilly, Galderma, Janssen-Ortho, Kyowa Hakko Kirin, Leo Pharma, Pfizer, and UCB Pharma.
Acknowledgements
Joshua Hekmatjah, Dr Nazanin Ehsani-Chimeh, and Dr April W. Armstrong would like to gratefully acknowledge Professor Howard Baden, a previous contributor to this topic.
Disclosures
HB declares that he has no competing interests.
Peer reviewers
Lowell Goldsmith, MD
Professor of Dermatology
Dean Emeritus
School of Medicine and Dentistry
University of North Carolina
Chapel Hill
NC
Disclosures
LG is editor-in-chief and co-founder of Logicalimages, Inc, which has print and electronic products for education and point-of-care; he has stock and stock options in that corporation. He is on the clinical and scientific advisory boards of Anacor Inc, which is developing anti-inflammatory and anti-infective products that are in early clinical trials; he receives payments and stock options for those services.
Dedee F. Murrell, MA, BMBCh, FAAD, MD
Head of Department
Department of Dermatology
St George Hospital
Conjoint Professor
University of New South Wales
Sydney
Australia
Disclosures
DFM declares that she has no competing interests.
References
Key articles
Lucky AW, Esterly NB, Heskel N, et al. Eosinophilic pustular folliculitis in infancy. Pediatric Dermatol. 1984 Jan;1(3):202-6. Abstract
Buckley DA, Munn SE, Higgins EM. Neonatal eosinophilic pustular folliculitis. Clinical Exp Dermatol. 2001 May;26(3):251-5. Abstract
Faergemann J. Pityrosporum infections. J Am Acad Dermatol. 1994 Sep;31(3 Pt 2):S18-20. Abstract
Ota T, Hata A, Tanikawa A, et al. Eosinophilic pustular folliculitis (Ofuji's disease): indomethacin as a first choice of treatment. Clin Exp Dermatol. 2001 Mar;26(2):179-81. Abstract
Oranje AP, Folkers E. The Tzanck smear: old, but still of inestimable value. Pediatr Dermatol. 1988 May;5(2):127-9. Abstract
Ranki A, Hyry H, Klimenko T, et al. Update on current care guidelines. Bacterial skin infections [in Finnish]. Duodecim. 2010;126(24):2883-4. Abstract
Reference articles
A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
Differentials
- Pseudofoliculite da barba
- Acne vulgar
- Rosácea
More Differentials
Log in or subscribe to access all of BMJ Best Practice
Use of this content is subject to our disclaimer